It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. As we’ve seen over… Read More »The US biosimilar market: Predictions for 2021
US wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 billion in a cash and shares deal. AmerisourceBergen will pay $6.275 billion in cash and around 2 million shares of its common stock for Alliance Healthcare in… Read More »AmerisourceBergen buys Walgreens Boots Alliance wholesaling business for $6.5bn
AmerisourceBergen plans to buy most of Walgreens’ Alliance Healthcare business for $6.5 billion. The deal will let Walgreens focus more on its retail pharmacy and healthcare businesses.